• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global and China Small Molecule Active Pharmaceutical Ingredient Market Insights, Forecast to 2026

report cover
  • 4 September 2020
  • Pharmaceuticals
  • 140 Pages
  • Report Code: 24LS-21584
  • Formate :   
Download FREE Report Sample Download PDF File

Small Molecule Active Pharmaceutical Ingredient -MARKET ADVISORY SERVICES

Small Molecule Active Pharmaceutical Ingredient market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Small Molecule Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Small Molecule Active Pharmaceutical Ingredient market is segmented into
Standard API
High Potency API

Segment by Application, the Small Molecule Active Pharmaceutical Ingredient market is segmented into
Cardiovascular Diseases
Respiratory Disorders
Infectious Diseases
Others

Regional and Country-level Analysis
The Small Molecule Active Pharmaceutical Ingredient market is analysed and market size information is provided by regions (countries).
The key regions covered in the Small Molecule Active Pharmaceutical Ingredient market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Small Molecule Active Pharmaceutical Ingredient Market Share Analysis
Small Molecule Active Pharmaceutical Ingredient market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Small Molecule Active Pharmaceutical Ingredient business, the date to enter into the Small Molecule Active Pharmaceutical Ingredient market, Small Molecule Active Pharmaceutical Ingredient product introduction, recent developments, etc.
The major vendors covered:
Johnson Matthey
Siegfried Holding AG
Pfizer
Sanofi S.A.
Novartis AG,
Bristol-Myers Squibb
Boehringer Ingelheim GmbH
GlaxoSmithKline
Albany Molecular Research Inc.
Bachem Holding AG
PCAS
Patheon N.V.
AstraZeneca
Johnson & Johnson
Merck & Co
BASF SE
Catalent Inc.
Teva Pharmaceuticals
Roche
Cambrex Corporation
GILEAD Science Inc.
1 Study Coverage
1.1 Small Molecule Active Pharmaceutical Ingredient Product Introduction
1.2 Market Segments
1.3 Key Small Molecule Active Pharmaceutical Ingredient Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type
1.4.2 Standard API
1.4.3 High Potency API
1.5 Market by Application
1.5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application
1.5.2 Cardiovascular Diseases
1.5.3 Respiratory Disorders
1.5.4 Infectious Diseases
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size, Estimates and Forecasts
2.1.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue 2015-2026
2.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales 2015-2026
2.2 Global Small Molecule Active Pharmaceutical Ingredient, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Small Molecule Active Pharmaceutical Ingredient Historical Market Size by Region (2015-2020)
2.3.1 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Small Molecule Active Pharmaceutical Ingredient Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Small Molecule Active Pharmaceutical Ingredient Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026)
2.4.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Region (2021-2026)

3 Global Small Molecule Active Pharmaceutical Ingredient Competitor Landscape by Players
3.1 Global Top Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers
3.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020)
3.1.2 Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Manufacturers (2015-2020)
3.2 Global Small Molecule Active Pharmaceutical Ingredient Manufacturers by Revenue
3.2.1 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020)
3.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Small Molecule Active Pharmaceutical Ingredient Revenue in 2019
3.2.5 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturers
3.4 Global Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Types
3.4.1 Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
3.4.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type (2015-2020)
4.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020)
4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020)
4.1.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Type (2021-2026)
4.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
4.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
4.2.3 Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Application (2015-2020)
5.1.1 Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020)
5.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Application (2015-2020)
5.1.3 Small Molecule Active Pharmaceutical Ingredient Price by Application (2015-2020)
5.2 Small Molecule Active Pharmaceutical Ingredient Market Size Forecast by Application (2021-2026)
5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
5.2.3 Global Small Molecule Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)

6 China by Players, Type and Application
6.1 China Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
6.1.1 China Small Molecule Active Pharmaceutical Ingredient Sales YoY Growth 2015-2026
6.1.2 China Small Molecule Active Pharmaceutical Ingredient Revenue YoY Growth 2015-2026
6.1.3 China Small Molecule Active Pharmaceutical Ingredient Market Share in Global Market 2015-2026
6.2 China Small Molecule Active Pharmaceutical Ingredient Market Size by Players (International and Local Players)
6.2.1 China Top Small Molecule Active Pharmaceutical Ingredient Players by Sales (2015-2020)
6.2.2 China Top Small Molecule Active Pharmaceutical Ingredient Players by Revenue (2015-2020)
6.3 China Small Molecule Active Pharmaceutical Ingredient Historic Market Review by Type (2015-2020)
6.3.1 China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)
6.3.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)
6.3.3 China Small Molecule Active Pharmaceutical Ingredient Price by Type (2015-2020)
6.4 China Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2026)
6.4.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Type (2021-2026)
6.4.3 China Small Molecule Active Pharmaceutical Ingredient Price Forecast by Type (2021-2026)
6.5 China Small Molecule Active Pharmaceutical Ingredient Historic Market Review by Application (2015-2020)
6.5.1 China Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
6.5.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
6.5.3 China Small Molecule Active Pharmaceutical Ingredient Price by Application (2015-2020)
6.6 China Small Molecule Active Pharmaceutical Ingredient Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2026)
6.6.2 China Small Molecule Active Pharmaceutical Ingredient Revenue Forecast by Application (2021-2026)
6.6.3 China Small Molecule Active Pharmaceutical Ingredient Price Forecast by Application (2021-2026)

7 North America
7.1 North America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
7.2 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
7.2.1 North America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020)
7.2.2 North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada

8 Europe
8.1 Europe Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
8.2 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
8.2.1 Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country
8.2.2 Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia

9 Asia Pacific
9.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
9.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
9.2.1 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region (2015-2020)
9.2.2 Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam

10 Latin America
10.1 Latin America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
10.2 Latin America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
10.2.1 Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country
10.2.2 Latin America Small Molecule Active Pharmaceutical Ingredient Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina

11 Middle East and Africa
11.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country
11.2.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country
11.2.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E

12 Company Profiles
12.1 Johnson Matthey
12.1.1 Johnson Matthey Corporation Information
12.1.2 Johnson Matthey Description and Business Overview
12.1.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
12.1.5 Johnson Matthey Recent Development
12.2 Siegfried Holding AG
12.2.1 Siegfried Holding AG Corporation Information
12.2.2 Siegfried Holding AG Description and Business Overview
12.2.3 Siegfried Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
12.2.5 Siegfried Holding AG Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Description and Business Overview
12.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
12.3.5 Pfizer Recent Development
12.4 Sanofi S.A.
12.4.1 Sanofi S.A. Corporation Information
12.4.2 Sanofi S.A. Description and Business Overview
12.4.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.4.5 Sanofi S.A. Recent Development
12.5 Novartis AG,
12.5.1 Novartis AG, Corporation Information
12.5.2 Novartis AG, Description and Business Overview
12.5.3 Novartis AG, Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
12.5.5 Novartis AG, Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Description and Business Overview
12.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Boehringer Ingelheim GmbH
12.7.1 Boehringer Ingelheim GmbH Corporation Information
12.7.2 Boehringer Ingelheim GmbH Description and Business Overview
12.7.3 Boehringer Ingelheim GmbH Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
12.7.5 Boehringer Ingelheim GmbH Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Description and Business Overview
12.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 Albany Molecular Research Inc.
12.9.1 Albany Molecular Research Inc. Corporation Information
12.9.2 Albany Molecular Research Inc. Description and Business Overview
12.9.3 Albany Molecular Research Inc. Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
12.9.5 Albany Molecular Research Inc. Recent Development
12.10 Bachem Holding AG
12.10.1 Bachem Holding AG Corporation Information
12.10.2 Bachem Holding AG Description and Business Overview
12.10.3 Bachem Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
12.10.5 Bachem Holding AG Recent Development
12.11 Johnson Matthey
12.11.1 Johnson Matthey Corporation Information
12.11.2 Johnson Matthey Description and Business Overview
12.11.3 Johnson Matthey Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
12.11.5 Johnson Matthey Recent Development
12.12 Patheon N.V.
12.12.1 Patheon N.V. Corporation Information
12.12.2 Patheon N.V. Description and Business Overview
12.12.3 Patheon N.V. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Patheon N.V. Products Offered
12.12.5 Patheon N.V. Recent Development
12.13 AstraZeneca
12.13.1 AstraZeneca Corporation Information
12.13.2 AstraZeneca Description and Business Overview
12.13.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
12.13.4 AstraZeneca Products Offered
12.13.5 AstraZeneca Recent Development
12.14 Johnson & Johnson
12.14.1 Johnson & Johnson Corporation Information
12.14.2 Johnson & Johnson Description and Business Overview
12.14.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Johnson & Johnson Products Offered
12.14.5 Johnson & Johnson Recent Development
12.15 Merck & Co
12.15.1 Merck & Co Corporation Information
12.15.2 Merck & Co Description and Business Overview
12.15.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Merck & Co Products Offered
12.15.5 Merck & Co Recent Development
12.16 BASF SE
12.16.1 BASF SE Corporation Information
12.16.2 BASF SE Description and Business Overview
12.16.3 BASF SE Sales, Revenue and Gross Margin (2015-2020)
12.16.4 BASF SE Products Offered
12.16.5 BASF SE Recent Development
12.17 Catalent Inc.
12.17.1 Catalent Inc. Corporation Information
12.17.2 Catalent Inc. Description and Business Overview
12.17.3 Catalent Inc. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Catalent Inc. Products Offered
12.17.5 Catalent Inc. Recent Development
12.18 Teva Pharmaceuticals
12.18.1 Teva Pharmaceuticals Corporation Information
12.18.2 Teva Pharmaceuticals Description and Business Overview
12.18.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Teva Pharmaceuticals Products Offered
12.18.5 Teva Pharmaceuticals Recent Development
12.19 Roche
12.19.1 Roche Corporation Information
12.19.2 Roche Description and Business Overview
12.19.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Roche Products Offered
12.19.5 Roche Recent Development
12.20 Cambrex Corporation
12.20.1 Cambrex Corporation Corporation Information
12.20.2 Cambrex Corporation Description and Business Overview
12.20.3 Cambrex Corporation Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Cambrex Corporation Products Offered
12.20.5 Cambrex Corporation Recent Development
12.21 GILEAD Science Inc.
12.21.1 GILEAD Science Inc. Corporation Information
12.21.2 GILEAD Science Inc. Description and Business Overview
12.21.3 GILEAD Science Inc. Sales, Revenue and Gross Margin (2015-2020)
12.21.4 GILEAD Science Inc. Products Offered
12.21.5 GILEAD Science Inc. Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Small Molecule Active Pharmaceutical Ingredient Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Small Molecule Active Pharmaceutical Ingredient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Small Molecule Active Pharmaceutical Ingredient Market Segments

Table 2. Ranking of Global Top Small Molecule Active Pharmaceutical Ingredient Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)

Table 4. Major Manufacturers of Standard API

Table 5. Major Manufacturers of High Potency API

Table 6. Global Small Molecule Active Pharmaceutical Ingredient Market Size Growth Rate by Application 2020-2026 (MT)

Table 7. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (MT) & (US$ Million): 2020 VS 2026

Table 8. Global Small Molecule Active Pharmaceutical Ingredient Sales by Regions 2015-2020 (MT)

Table 9. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)

Table 10. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Regions 2015-2020 (US$ Million)

Table 11. Global Small Molecule Active Pharmaceutical Ingredient Sales Forecast by Region (2021-2026) (MT)

Table 12. Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturers (2015-2020) (MT)

Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturers (2015-2020)

Table 14. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 15. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2019)

Table 16. Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturers (2015-2020) (US$ Million)

Table 17. Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturers (2015-2020)

Table 18. Key Manufacturers Small Molecule Active Pharmaceutical Ingredient Price (2015-2020) (USD/MT)

Table 19. Small Molecule Active Pharmaceutical Ingredient Manufacturers Manufacturing Base Distribution and Headquarters

Table 20. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type

Table 21. Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market

Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 23. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2015-2020) (MT)

Table 24. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)

Table 25. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (US$ Million)

Table 26. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)

Table 27. Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type 2015-2020 (USD/MT)

Table 28. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2021-2026)

Table 29. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2015-2020) (MT)

Table 30. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)

Table 31. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2021-2026)

Table 32. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share Forecast by Application (2021-2026)

Table 33. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Application (2015-2020) (US$ Million)

Table 34. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share Forecast by Application (2021-2026)

Table 35. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) of Key Companies (2015-2020)

Table 36. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Company (2015-2020)

Table 37. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) by Company (2015-2020)

Table 38. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2015-2020)

Table 39. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)

Table 40. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2015-2020)

Table 41. China Small Molecule Active Pharmaceutical Ingredient Price (MT) by Type (2015-2020)

Table 42. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Type (2021-2026)

Table 43. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Type (2021-2026)

Table 44. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Type (2021-2026)

Table 45. China Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2021-2026)

Table 46. China Small Molecule Active Pharmaceutical Ingredient Price (MT) by Type (2021-2026)

Table 47. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2015-2020)

Table 48. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)

Table 49. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2015-2020)

Table 50. China Small Molecule Active Pharmaceutical Ingredient Sales (MT) by Application (2021-2026)

Table 51. China Small Molecule Active Pharmaceutical Ingredient Sales Share by Application (2021-2026)

Table 52. China Small Molecule Active Pharmaceutical Ingredient Revenue (US$ Million) Market Share by Application (2021-2026)

Table 53. China Small Molecule Active Pharmaceutical Ingredient Revenue Share by Application (2021-2026)

Table 54. North America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)

Table 55. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)

Table 56. North America Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)

Table 57. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)

Table 58. Europe Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)

Table 59. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)

Table 60. Europe Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)

Table 61. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)

Table 62. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales by Region (2015-2020) (MT)

Table 63. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)

Table 64. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue by Region (2015-2020) (US$ Million)

Table 65. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)

Table 66. Latin America Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)

Table 67. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)

Table 68. Latin Americaa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)

Table 69. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales by Country (2015-2020) (MT)

Table 71. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country (2015-2020)

Table 72. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue by Country (2015-2020) (US$ Million)

Table 73. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country (2015-2020)

Table 74. Johnson Matthey Corporation Information

Table 75. Johnson Matthey Description and Business Overview

Table 76. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 77. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product

Table 78. Johnson Matthey Recent Development

Table 79. Siegfried Holding AG Corporation Information

Table 80. Siegfried Holding AG Description and Business Overview

Table 81. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 82. Siegfried Holding AG Product

Table 83. Siegfried Holding AG Recent Development

Table 84. Pfizer Corporation Information

Table 85. Pfizer Description and Business Overview

Table 86. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 87. Pfizer Product

Table 88. Pfizer Recent Development

Table 89. Sanofi S.A. Corporation Information

Table 90. Sanofi S.A. Description and Business Overview

Table 91. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 92. Sanofi S.A. Product

Table 93. Sanofi S.A. Recent Development

Table 94. Novartis AG, Corporation Information

Table 95. Novartis AG, Description and Business Overview

Table 96. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 97. Novartis AG, Product

Table 98. Novartis AG, Recent Development

Table 99. Bristol-Myers Squibb Corporation Information

Table 100. Bristol-Myers Squibb Description and Business Overview

Table 101. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 102. Bristol-Myers Squibb Product

Table 103. Bristol-Myers Squibb Recent Development

Table 104. Boehringer Ingelheim GmbH Corporation Information

Table 105. Boehringer Ingelheim GmbH Description and Business Overview

Table 106. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 107. Boehringer Ingelheim GmbH Product

Table 108. Boehringer Ingelheim GmbH Recent Development

Table 109. GlaxoSmithKline Corporation Information

Table 110. GlaxoSmithKline Description and Business Overview

Table 111. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 112. GlaxoSmithKline Product

Table 113. GlaxoSmithKline Recent Development

Table 114. Albany Molecular Research Inc. Corporation Information

Table 115. Albany Molecular Research Inc. Description and Business Overview

Table 116. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 117. Albany Molecular Research Inc. Product

Table 118. Albany Molecular Research Inc. Recent Development

Table 119. Bachem Holding AG Corporation Information

Table 120. Bachem Holding AG Description and Business Overview

Table 121. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 122. Bachem Holding AG Product

Table 123. Bachem Holding AG Recent Development

Table 124. PCAS Corporation Information

Table 125. PCAS Description and Business Overview

Table 126. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 127. PCAS Product

Table 128. PCAS Recent Development

Table 129. Patheon N.V. Corporation Information

Table 130. Patheon N.V. Description and Business Overview

Table 131. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 132. Patheon N.V. Product

Table 133. Patheon N.V. Recent Development

Table 134. AstraZeneca Corporation Information

Table 135. AstraZeneca Description and Business Overview

Table 136. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 137. AstraZeneca Product

Table 138. AstraZeneca Recent Development

Table 139. Johnson & Johnson Corporation Information

Table 140. Johnson & Johnson Description and Business Overview

Table 141. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 142. Johnson & Johnson Product

Table 143. Johnson & Johnson Recent Development

Table 144. Merck & Co Corporation Information

Table 145. Merck & Co Description and Business Overview

Table 146. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 147. Merck & Co Product

Table 148. Merck & Co Recent Development

Table 149. BASF SE Corporation Information

Table 150. BASF SE Description and Business Overview

Table 151. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 152. BASF SE Product

Table 153. BASF SE Recent Development

Table 154. Catalent Inc. Corporation Information

Table 155. Catalent Inc. Description and Business Overview

Table 156. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 157. Catalent Inc. Product

Table 158. Catalent Inc. Recent Development

Table 159. Teva Pharmaceuticals Corporation Information

Table 160. Teva Pharmaceuticals Description and Business Overview

Table 161. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 162. Teva Pharmaceuticals Product

Table 163. Teva Pharmaceuticals Recent Development

Table 164. Roche Corporation Information

Table 165. Roche Description and Business Overview

Table 166. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 167. Roche Product

Table 168. Roche Recent Development

Table 169. Cambrex Corporation Corporation Information

Table 170. Cambrex Corporation Description and Business Overview

Table 171. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 172. Cambrex Corporation Product

Table 173. Cambrex Corporation Recent Development

Table 174. GILEAD Science Inc. Corporation Information

Table 175. GILEAD Science Inc. Description and Business Overview

Table 176. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)

Table 177. GILEAD Science Inc. Product

Table 178. GILEAD Science Inc. Recent Development

Table 179. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 180. Key Challenges

Table 181. Market Risks

Table 182. Main Points Interviewed from Key Small Molecule Active Pharmaceutical Ingredient Players

Table 183. Small Molecule Active Pharmaceutical Ingredient Customers List

Table 184. Small Molecule Active Pharmaceutical Ingredient Distributors List

Table 185. Research Programs/Design for This Report

Table 186. Key Data Information from Secondary Sources

Table 187. Key Data Information from Primary Sources

List of Figures

Figure 1. Small Molecule Active Pharmaceutical Ingredient Product Picture

Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2020 & 2026

Figure 3. Standard API Product Picture

Figure 4. High Potency API Product Picture

Figure 5. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2020 & 2026

Figure 6. Cardiovascular Diseases

Figure 7. Respiratory Disorders

Figure 8. Infectious Diseases

Figure 9. Others

Figure 10. Small Molecule Active Pharmaceutical Ingredient Report Years Considered

Figure 11. Global Small Molecule Active Pharmaceutical Ingredient Market Size 2015-2026 (US$ Million)

Figure 12. Global Small Molecule Active Pharmaceutical Ingredient Sales 2015-2026 (MT)

Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Market Size Market Share by Region: 2020 Versus 2026

Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region (2015-2020)

Figure 15. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2019

Figure 16. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region (2015-2020)

Figure 17. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019

Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturer in 2019

Figure 19. The Top 10 and 5 Players Market Share by Small Molecule Active Pharmaceutical Ingredient Revenue in 2019

Figure 20. Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 21. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type (2015-2020)

Figure 22. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Type in 2019

Figure 23. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type (2015-2020)

Figure 24. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Type in 2019

Figure 25. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Price Range (2015-2020)

Figure 26. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)

Figure 27. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Application in 2019

Figure 28. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)

Figure 29. Global Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Application in 2019

Figure 30. China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2026 (MT)

Figure 31. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2026 (US$ Million)

Figure 32. China Small Molecule Active Pharmaceutical Ingredient Market Share in Global Market 2015-2026

Figure 33. China 5 and 10 Largest Small Molecule Active Pharmaceutical Ingredient Players Market Share by Revenue in Small Molecule Active Pharmaceutical Ingredient in 2019

Figure 34. China Small Molecule Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)

Figure 35. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate by Type in 2015 & 2019

Figure 36. China Small Molecule Active Pharmaceutical Ingredient Revenue Share by Application (2015-2020)

Figure 37. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate by Application in 2015 & 2019

Figure 38. North America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)

Figure 39. North America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)

Figure 40. North America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019

Figure 41. North America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019

Figure 42. U.S. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 43. U.S. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 44. Canada Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 45. Canada Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 46. Europe Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)

Figure 47. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)

Figure 48. Europe Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019

Figure 49. Europe Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019

Figure 50. Germany Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 51. Germany Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 52. France Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 53. France Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 54. U.K. Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 55. U.K. Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 56. Italy Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 57. Italy Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 58. Russia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 59. Russia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 60. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)

Figure 61. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)

Figure 62. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Region in 2019

Figure 63. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Region in 2019

Figure 64. China Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 65. China Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 66. Japan Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 67. Japan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 68. South Korea Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 69. South Korea Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 70. India Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 71. India Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 72. Australia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 73. Australia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 74. Taiwan Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 75. Taiwan Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 76. Indonesia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 77. Indonesia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 78. Thailand Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 79. Thailand Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 80. Malaysia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 81. Malaysia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 82. Philippines Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 83. Philippines Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 84. Vietnam Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 85. Vietnam Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 86. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)

Figure 87. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)

Figure 88. Latin America Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019

Figure 89. Latin America Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019

Figure 90. Mexico Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 91. Mexico Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 92. Brazil Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 93. Brazil Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 94. Argentina Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 95. Argentina Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 96. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate 2015-2020 (MT)

Figure 97. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate 2015-2020 (US$ Million)

Figure 98. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales Market Share by Country in 2019

Figure 99. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Revenue Market Share by Country in 2019

Figure 100. Turkey Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 101. Turkey Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 102. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 103. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 104. U.A.E Small Molecule Active Pharmaceutical Ingredient Sales Growth Rate (2015-2020) (MT)

Figure 105. U.A.E Small Molecule Active Pharmaceutical Ingredient Revenue Growth Rate (2015-2020) (US$ Million)

Figure 106. Porter's Five Forces Analysis

Figure 107. Small Molecule Active Pharmaceutical Ingredient Value Chain

Figure 108. Channels of Distribution

Figure 109. Distributors Profiles

Figure 110. Bottom-up and Top-down Approaches for This Report

Figure 111. Data Triangulation

Figure 112. Key Executives Interviewed

Johnson Matthey

Siegfried Holding AG

Pfizer

Sanofi S.A.

Novartis AG,

Bristol-Myers Squibb

Boehringer Ingelheim GmbH

GlaxoSmithKline

Albany Molecular Research Inc.

Bachem Holding AG

PCAS

Patheon N.V.

AstraZeneca

Johnson & Johnson

Merck & Co

BASF SE

Catalent Inc.

Teva Pharmaceuticals

Roche

Cambrex Corporation

GILEAD Science Inc.

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2925

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase